Randomized Trial of Beta-Carotene and Macular Degeneration
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine whether 50 mg of beta-carotene taken every other day reduces the risk of
developing age-related macular degeneration (AMD) among male U.S. physicians who were aged 40
to 84 in 1982.
To investigate the possible relationship of AMD with other antioxidants, including selenium
and vitamins A, C, and E.
To identify potential risk factors for development of AMD. Possible risk factors include
height, systemic hypertension, cardiovascular disease, blood cholesterol, cigarette smoking,
iris and skin color, sunlight exposure, body mass index, diabetes, and alcohol intake.